Mechanisms and management strategies for exacerbated bone loss following denosumab discontinuation
This review systematically summarizes the potential mechanisms underlying exacerbated bone loss after denosumab withdrawal and the corresponding sequential treatment strategies, and emerging strategies such as early transition to romosozumab or alternating use with bisphosphonates have shown potential.